Donor, patient age and exposure to antibiotics are associated with the outcome of faecal microbiota transplantation for recurrent Clostridioides difficile infection: A prospective cohort study
Alimentary Pharmacology & Therapeutics · 2023-09 · 58 (5) · 503-515
DOI: 10.1111/apt.17642 ↗At a glance
Kohortenstudie in Alimentary Pharmacology & Therapeutics, published online on 2023-07-22. Written by Simon M D Baunwall and 10 co-authors. Institution: Department of Hepatology and Gastroenterology, Aarhus University Hospital, Aarhus, Denmark. Major MEDLINE topics: Fecal Microbiota Transplantation, Clostridium Infections. Cited 17 times so far (Crossref); 30 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Innovationsfonden, Lundbeckfonden, Novo Nordisk Fonden.
Abstract (original language)
Background
Faecal microbiota transplantation (FMT) is effective for recurrent Clostridioides difficile infection (rCDI), but its effect varies inexplicably.
Aims
To optimise the effectiveness of FMT for rCDI and validate determinants for effect Methods We conducted a cohort study, including all patients treated with FMT for rCDI between October 2018 and June 2020. Statistical process control was used to evaluate the impact of prospective quality improvement on the effect of single FMT treatments per 10–11 patients. Targeting an 80% effect, optimisations included changes to processing procedures, preparation and clinical application of FMT. The primary outcome was the resolution of Clostridioides difficile ‐associated diarrhoea at week 8. If CDI recurred, FMT was repeated. All patients were followed for 8 weeks after their latest FMT.
Results
183 patients with rCDI received 290 FMT treatments. A single FMT achieved resolution at week 8 in 127 (69%, 95% CI: 62%–76%), while repeated FMT cumulatively achieved resolution in 167/183 (91%, 95% CI: 86%–95%). The single FMT effect varied between 36% and 100% over time. In a mixed‐effect model, patient age above 65 years, non‐rCDI antibiotics at week 1 post‐FMT, and donor were associated with effect. Neither increasing the dosages of faecal microbes nor standardising the processing improved outcomes.
Conclusion
FMT has a high cumulative effectiveness in patients with rCDI following multiple administrations, but the single FMT effect is variable and may be optimised using statistical process control. Optimising FMT by considering patient age, post‐FMT antibiotics, donor and multiple administrations may improve the treatment outcomes. ClinicalTrials.gov (Study identifier: NCT03712722).
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Hepatology and Gastroenterology, Aarhus University Hospital, Aarhus, Denmark.
- Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
- Department of Clinical Immunology, Aarhus University Hospital, Aarhus, Denmark.
ORCID profiles: Simon M D Baunwall
Funding
- Innovationsfonden
- Lundbeckfonden
- Novo Nordisk Fonden
Cite
APA
Baunwall, S. M. D., Hansen, M. M., Andreasen, S. E., Eriksen, M. K., Rågård, N., Kelsen, J., Grosen, A. K., Mikkelsen, S., Erikstrup, C., Dahlerup, J. F., & Hvas, C. L. (2023). Donor, patient age and exposure to antibiotics are associated with the outcome of faecal microbiota transplantation for recurrent Clostridioides difficile infection: A prospective cohort study. Alimentary Pharmacology & Therapeutics, 58(5), 503-515. https://doi.org/10.1111/apt.17642
Vancouver
Baunwall SMD, Hansen MM, Andreasen SE, Eriksen MK, Rågård N, Kelsen J, et al. Donor, patient age and exposure to antibiotics are associated with the outcome of faecal microbiota transplantation for recurrent Clostridioides difficile infection: A prospective cohort study. Alimentary Pharmacology & Therapeutics. 2023;58(5):503-515. doi:10.1111/apt.17642
BibTeX
@article{Baunwall2023,
author = {Baunwall, Simon M D and Hansen, Mette M and Andreasen, Sara E and Eriksen, Marcel K and Rågård, Nina and Kelsen, Jens and Grosen, Anne K and Mikkelsen, Susan and Erikstrup, Christian and Dahlerup, Jens F and Hvas, Christian L},
title = {Donor, patient age and exposure to antibiotics are associated with the outcome of faecal microbiota transplantation for recurrent Clostridioides difficile infection: A prospective cohort study},
journal = {Alimentary Pharmacology & Therapeutics},
year = {2023},
volume = {58},
number = {5},
pages = {503--515},
doi = {10.1111/apt.17642}
}
EUVIMED